
J. R. Mcdowell
Examiner (ID: 446)
| Most Active Art Unit | 2612 |
| Art Unit(s) | 2612, 2628, 2677, 2678 |
| Total Applications | 1124 |
| Issued Applications | 974 |
| Pending Applications | 48 |
| Abandoned Applications | 123 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 8096265
[patent_doc_number] => 20120083747
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2012-04-05
[patent_title] => 'Vaginal renewal complex and applicator'
[patent_app_type] => utility
[patent_app_number] => 13/200851
[patent_app_country] => US
[patent_app_date] => 2011-10-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 952
[patent_no_of_claims] => 6
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0083/20120083747.pdf
[firstpage_image] =>[orig_patent_app_number] => 13200851
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/200851 | Vaginal renewal complex and applicator | Oct 2, 2011 | Abandoned |
Array
(
[id] => 7490565
[patent_doc_number] => 20110237618
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-09-29
[patent_title] => 'METHODS FOR TREATING MIGRAINES WITH HUPERZINE A DERIVATIVES'
[patent_app_type] => utility
[patent_app_number] => 13/154398
[patent_app_country] => US
[patent_app_date] => 2011-06-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5126
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0237/20110237618.pdf
[firstpage_image] =>[orig_patent_app_number] => 13154398
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/154398 | METHODS FOR TREATING MIGRAINES WITH HUPERZINE A DERIVATIVES | Jun 5, 2011 | Abandoned |
| 12/991353 | MODULATORS OF MCAM IN THE TREATMENT OF ACNE, OF SEBORRHOEIC DERMATITIS OR OF HYPERSEBORRHOEA | Feb 23, 2011 | Abandoned |
Array
(
[id] => 7587326
[patent_doc_number] => 20110281836
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-11-17
[patent_title] => 'Silent desensitizers of neuronal NACHR and methods of use thereof'
[patent_app_type] => utility
[patent_app_number] => 12/927688
[patent_app_country] => US
[patent_app_date] => 2010-11-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 9
[patent_no_of_words] => 16991
[patent_no_of_claims] => 70
[patent_no_of_ind_claims] => 51
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0281/20110281836.pdf
[firstpage_image] =>[orig_patent_app_number] => 12927688
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/927688 | Silent desensitizers of neuronal NACHR and methods of use thereof | Nov 18, 2010 | Abandoned |
Array
(
[id] => 5944939
[patent_doc_number] => 20110105559
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-05-05
[patent_title] => 'Compositions and Methods for Treating, Controlling, Reducing, Ameliorating, or Preventing Allergy'
[patent_app_type] => utility
[patent_app_number] => 12/909387
[patent_app_country] => US
[patent_app_date] => 2010-10-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 14
[patent_figures_cnt] => 14
[patent_no_of_words] => 50233
[patent_no_of_claims] => 7
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0105/20110105559.pdf
[firstpage_image] =>[orig_patent_app_number] => 12909387
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/909387 | Compositions and Methods for Treating, Controlling, Reducing, Ameliorating, or Preventing Allergy | Oct 20, 2010 | Abandoned |
Array
(
[id] => 7656514
[patent_doc_number] => 20110305783
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-12-15
[patent_title] => 'Method and pharmaceutical composition for treating psoriasis, squamous cell carcinoma and/or parakeratosis by inhibiting expression of squamous cell carcinoma-related antigen'
[patent_app_type] => utility
[patent_app_number] => 12/907412
[patent_app_country] => US
[patent_app_date] => 2010-10-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 14
[patent_figures_cnt] => 14
[patent_no_of_words] => 14748
[patent_no_of_claims] => 3
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0305/20110305783.pdf
[firstpage_image] =>[orig_patent_app_number] => 12907412
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/907412 | Method and pharmaceutical composition for treating psoriasis, squamous cell carcinoma and/or parakeratosis by inhibiting expression of squamous cell carcinoma-related antigen | Oct 18, 2010 | Abandoned |
Array
(
[id] => 8244958
[patent_doc_number] => 08202886
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2012-06-19
[patent_title] => 'Small molecule E2F inhibitor'
[patent_app_type] => utility
[patent_app_number] => 12/872263
[patent_app_country] => US
[patent_app_date] => 2010-08-31
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 25
[patent_figures_cnt] => 28
[patent_no_of_words] => 9630
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 21
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/08/202/08202886.pdf
[firstpage_image] =>[orig_patent_app_number] => 12872263
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/872263 | Small molecule E2F inhibitor | Aug 30, 2010 | Issued |
Array
(
[id] => 5943648
[patent_doc_number] => 20110104268
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-05-05
[patent_title] => 'GALENIC APPLICATIONS OF SELF-EMULSIFYING MIXTURES OF LIPIDIC EXCIPIENTS'
[patent_app_type] => utility
[patent_app_number] => 12/870250
[patent_app_country] => US
[patent_app_date] => 2010-08-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 8073
[patent_no_of_claims] => 38
[patent_no_of_ind_claims] => 7
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0104/20110104268.pdf
[firstpage_image] =>[orig_patent_app_number] => 12870250
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/870250 | GALENIC APPLICATIONS OF SELF-EMULSIFYING MIXTURES OF LIPIDIC EXCIPIENTS | Aug 26, 2010 | Abandoned |
Array
(
[id] => 6645330
[patent_doc_number] => 20100227922
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-09-09
[patent_title] => 'Long-term stable pharmaceutical preparation containing the active ingredient glyceryl trinitrate'
[patent_app_type] => utility
[patent_app_number] => 12/789217
[patent_app_country] => US
[patent_app_date] => 2010-05-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 3577
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0227/20100227922.pdf
[firstpage_image] =>[orig_patent_app_number] => 12789217
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/789217 | Long-term stable pharmaceutical preparation containing the active ingredient glyceryl trinitrate | May 26, 2010 | Issued |
Array
(
[id] => 6267841
[patent_doc_number] => 20100298430
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-11-25
[patent_title] => 'PROPHYLACTIC ANTISTRESS AGENT'
[patent_app_type] => utility
[patent_app_number] => 12/786910
[patent_app_country] => US
[patent_app_date] => 2010-05-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 2434
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0298/20100298430.pdf
[firstpage_image] =>[orig_patent_app_number] => 12786910
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/786910 | PROPHYLACTIC ANTISTRESS AGENT | May 24, 2010 | Abandoned |
Array
(
[id] => 7683701
[patent_doc_number] => 20100240710
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-09-23
[patent_title] => 'Use of Pyridoxamine to Treat and/or Prevent Disease Processes'
[patent_app_type] => utility
[patent_app_number] => 12/775641
[patent_app_country] => US
[patent_app_date] => 2010-05-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 12948
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0240/20100240710.pdf
[firstpage_image] =>[orig_patent_app_number] => 12775641
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/775641 | Use of Pyridoxamine to Treat and/or Prevent Disease Processes | May 6, 2010 | Abandoned |
Array
(
[id] => 6276332
[patent_doc_number] => 20100256214
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-10-07
[patent_title] => 'EPH RECEPTOR LIGANDS AND METHODS OF USE'
[patent_app_type] => utility
[patent_app_number] => 12/751203
[patent_app_country] => US
[patent_app_date] => 2010-03-31
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 25
[patent_figures_cnt] => 25
[patent_no_of_words] => 35188
[patent_no_of_claims] => 63
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0256/20100256214.pdf
[firstpage_image] =>[orig_patent_app_number] => 12751203
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/751203 | EPH RECEPTOR LIGANDS AND METHODS OF USE | Mar 30, 2010 | Abandoned |
Array
(
[id] => 6517477
[patent_doc_number] => 20100216893
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-08-26
[patent_title] => 'Long-term stable pharmaceutical preparation containing the active ingredient glycerol trinitrate'
[patent_app_type] => utility
[patent_app_number] => 12/752070
[patent_app_country] => US
[patent_app_date] => 2010-03-31
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 3546
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0216/20100216893.pdf
[firstpage_image] =>[orig_patent_app_number] => 12752070
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/752070 | Long-term stable pharmaceutical preparation containing the active ingredient glycerol trinitrate | Mar 30, 2010 | Abandoned |
Array
(
[id] => 6637358
[patent_doc_number] => 20100173856
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-07-08
[patent_title] => 'METHODS OF PRODUCING AND USING NUTRITIONAL AND PHARMACEUTICAL COMPOSITIONS THAT INCLUDE ONE OR MORE ACTIVE SUBSTANCES'
[patent_app_type] => utility
[patent_app_number] => 12/728992
[patent_app_country] => US
[patent_app_date] => 2010-03-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 3781
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0173/20100173856.pdf
[firstpage_image] =>[orig_patent_app_number] => 12728992
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/728992 | METHODS OF PRODUCING AND USING NUTRITIONAL AND PHARMACEUTICAL COMPOSITIONS THAT INCLUDE ONE OR MORE ACTIVE SUBSTANCES | Mar 21, 2010 | Abandoned |
Array
(
[id] => 7703021
[patent_doc_number] => 08088775
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2012-01-03
[patent_title] => 'Pharmaceutical composition for treating hair loss'
[patent_app_type] => utility
[patent_app_number] => 12/722720
[patent_app_country] => US
[patent_app_date] => 2010-03-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 6
[patent_no_of_words] => 6795
[patent_no_of_claims] => 6
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 56
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/08/088/08088775.pdf
[firstpage_image] =>[orig_patent_app_number] => 12722720
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/722720 | Pharmaceutical composition for treating hair loss | Mar 11, 2010 | Issued |
Array
(
[id] => 6195604
[patent_doc_number] => 20110027359
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-02-03
[patent_title] => 'Novel Pharmaceutical Compositions Comprising Levetiracetam'
[patent_app_type] => utility
[patent_app_number] => 12/720768
[patent_app_country] => US
[patent_app_date] => 2010-03-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5612
[patent_no_of_claims] => 31
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0027/20110027359.pdf
[firstpage_image] =>[orig_patent_app_number] => 12720768
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/720768 | Novel Pharmaceutical Compositions Comprising Levetiracetam | Mar 9, 2010 | Abandoned |
Array
(
[id] => 8305979
[patent_doc_number] => 08227514
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2012-07-24
[patent_title] => 'Topical application of travoprost for combating hair loss'
[patent_app_type] => utility
[patent_app_number] => 12/710382
[patent_app_country] => US
[patent_app_date] => 2010-02-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 5
[patent_no_of_words] => 8111
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 106
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12710382
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/710382 | Topical application of travoprost for combating hair loss | Feb 22, 2010 | Issued |
Array
(
[id] => 6590196
[patent_doc_number] => 20100130461
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-05-27
[patent_title] => 'Pharmaceutical composition for topical application'
[patent_app_type] => utility
[patent_app_number] => 12/657663
[patent_app_country] => US
[patent_app_date] => 2010-01-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 2604
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0130/20100130461.pdf
[firstpage_image] =>[orig_patent_app_number] => 12657663
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/657663 | Pharmaceutical composition for topical application | Jan 25, 2010 | Abandoned |
Array
(
[id] => 6638605
[patent_doc_number] => 20100173956
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-07-08
[patent_title] => 'Use of Quaternary Pyridinium Salts as Vasoprotective Agents'
[patent_app_type] => utility
[patent_app_number] => 12/685377
[patent_app_country] => US
[patent_app_date] => 2010-01-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 4143
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0173/20100173956.pdf
[firstpage_image] =>[orig_patent_app_number] => 12685377
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/685377 | Use of quaternary pyridinium salts as vasoprotective agents | Jan 10, 2010 | Issued |
Array
(
[id] => 6307714
[patent_doc_number] => 20100069498
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-03-18
[patent_title] => 'USE OF ALPHA-KETOGLUTARIC ACID FOR THE TREATMENT OF HIGH PLASMA GLUCOSE CONDITION'
[patent_app_type] => utility
[patent_app_number] => 12/626549
[patent_app_country] => US
[patent_app_date] => 2009-11-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 11108
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0069/20100069498.pdf
[firstpage_image] =>[orig_patent_app_number] => 12626549
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/626549 | USE OF ALPHA-KETOGLUTARIC ACID FOR THE TREATMENT OF HIGH PLASMA GLUCOSE CONDITION | Nov 24, 2009 | Abandoned |